Trust Co. of Vermont Purchases New Position in Danaher Corporation $DHR

Trust Co. of Vermont acquired a new position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 20,696 shares of the conglomerate’s stock, valued at approximately $3,942,000.

Several other institutional investors and hedge funds have also made changes to their positions in DHR. Main Street Group LTD purchased a new position in Danaher during the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new stake in Danaher in the second quarter valued at approximately $25,000. JPL Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $26,000. Finally, WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter worth approximately $26,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Down 0.0%

NYSE DHR opened at $202.44 on Tuesday. The stock has a market capitalization of $142.31 billion, a P/E ratio of 35.96, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a 50-day moving average price of $193.52 and a 200 day moving average price of $192.67. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the previous year, the company earned $0.77 EPS. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. Equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on DHR shares. Royal Bank Of Canada upped their price target on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Morgan Stanley dropped their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. HSBC reduced their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Finally, Stifel Nicolaus lowered their target price on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.